Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relmada Therapeutics, Inc.

0.3630
+0.01333.80%
Volume:1.16M
Turnover:415.46K
Market Cap:12.05M
PE:-0.14
High:0.3841
Open:0.3498
Low:0.3316
Close:0.3497
Loading ...
Apr 19, 2023

Major Issues Report

8-K - Current report
Mar 23, 2023

Major Issues Report

8-K - Current report
Mar 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 17, 2023

Major Issues Report

8-K - Current report
Jan 09, 2023

Major Issues Report

8-K - Current report
Jan 05, 2023

Major Issues Report

8-K - Current report
Dec 28, 2022

Major Issues Report

8-K - Current report
Dec 20, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2022

Major Issues Report

8-K - Current report